|
| Andhra Pradesh ~ India ~ International ~ City ~ Entertainment ~ Business ~ Bullion ~ Forex ~ Sports ~ Technology ~ Health ~ Features |
|
Home
/ Technology News / 2008 / February 2008 / February 8, 2008 HIV drugs Abacavir, Didanosine boost heart attack risk |
Stem cell heart surgery may spell the end for transplantation
Two-drug BP therapy can prevent heart attack, stroke
Worlds fastest personal supercomputer unveiled
An American company has unveiled the worlds first personal supercomputer, which is 250 times faster than the average PCs. ANI
Dark matter in our Universe is just right for life
A new model by a scientist has determined that the amount of dark matter in our Universe is just right for life to emerge. ANI
Robot that jumps like a grasshopper, rolls like a ball developed
A student at the University of Bath has developed a robot that can jump like a grasshopper and roll like a ball. ANI
A recent study has found that two widely used HIV drugs, Abacavir and Didanosine, can increase the risk of heart attack or formation of blood clots in the heart.
Washington, Feb 8 : A recent study has found that two widely used HIV drugs, Abacavir and Didanosine, can increase the risk of heart attack or formation of blood clots in the heart.
In the Data Collection of Adverse effects of Anti-HIV Drugs Study (D:A:D), the scientists observed the side effects and incidence of heart attack among HIV-infected patients using Stavudine, Zidovudine, Lamivudine, Abacavir and Didanosine.
The findings revealed that Didanosine increased risk the risk of developing heart attacks by 49 percent while Abacavir increased risk the by 90 percent.
The effect of drug in patients with high underlying cardiovascular risk increased by a factor of 1.9 for a person on Abacavir, and 1.49 for a person on Didanosine.
The study showed that risk of heart attack is removed once patients stop taking the drugs. However, the scientists recommended that HIV patients should not stop taking Abacavir or Didanosine before consulting their doctor.
ANI
